Hypertensive Disorders of Pregnancy Across the Range of Gravidity.
Article Sidebar
Main Article Content
Abstract
Objective: To compare the pre-eclampsia and eclampsia frequency in Primigravida and multigravida women who presented to the labor room of Saidu Teaching Hospitals, Swat.
Methodology:
The study was a retrospective cross-sectional case study between 1st January 2024 to 31st December 2024 involving 12498 admissions to the labor room by pursuing the convenience sampling method. Pregnant women who had either eclampsia and/or pre-eclampsia and were aged at ³18 years during the time of study in the labor room were the study subjects. The study excluded patients having protein losing enteropathy, conditions of uric acid or disorders of the kidneys such as nephrotic syndrome, diabetes Mellites and liver diseases. Statistical analysis included descriptive statistics, chi square test, and odds ratio calculations to compare the prevalence of hypertensive disorders between Primigravida and multigravida women.
Results:
The frequency of preeclampsia and eclampsia was 3.3% among Primigravida women and 12.8% among multigravida women (p<0.05). Women who had more than one pregnancy were much more likely to get these conditions, especially those over 35 years old. Limited access to antenatal care and increasing maternal age were recognized as significant factors contributing to the elevated prevalence among multigravida women.
Conclusion:
In this study, multigravida women are substantially more likely to experience hypertensive disorders during pregnancy. The results show that improved prenatal care is necessary to effectively address the increasing burden of these conditions.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
1. World Health Organization. Trends in maternal mortality 2000 to 2020. Geneva: World Health Organization; 2021.
2. Faiza, Sultana R, Batool J, Khalid S, Khan AM. Frequency of primigravida in patients with eclampsia. J Ayub Med Coll Abbottabad. 2023;35(2):265–268.
3. Magee LA, von Dadelszen P. Management of hypertensive disorders of pregnancy. BMJ. 2022;377:e060912. doi:10.1136/bmj-2021-060912.
4. Sibai BM, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005 Feb 26–Mar 4;365(9461):785–799. doi:10.1016/S0140-6736(05)17987-2. PMID: 15733721.
5. Barton JR, Sibai BM. Prediction and prevention of recurrent pre-eclampsia. Obstet Gynecol. 2020;135(3):501–510. doi:10.1097/AOG.0000000000003700.
6. Anto EO, Boadu WIO, Ansah E, Tawiah A, Frimpong J, Tamakloe VCKT, et al. Prevalence of preeclampsia and algorithm of adverse foeto-maternal risk factors among pregnant women in the Central Region of Ghana: a multicentre prospective cross-sectional study. PLoS One. 2023;18(6):e0288079. doi:10.1371/journal.pone.0288079.
7. von Dadelszen P, Magee LA. Pre-eclampsia: an update. Curr Opin Obstet Gynecol. 2021;33(2):72–78. doi:10.1097/GCO.0000000000000670.
8. Adjie JMS, Angkawijaya C. Profile of preeclampsia patients with aggravating factors: a retrospective study. Open Public Health J. 2023;16. doi:10.2174/0118749445241244231123111732.
9. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010 Aug 21;376(9741):631–644. doi:10.1016/S0140-6736(10)60279-6. PMID: 20598363.
10. Rana A. Prevalence and risk factors of hypertensive disorders in pregnancy in India. Int J Reprod Med. 2020;2020:1–8. doi:10.1155/2020/7482065.
11. Malik N, Khan AB, Khan FI, Shafiq M, Sarwar I. Pre-eclampsia: a major cause of maternal morbidity. Pak J Med Health Sci. 2020;14(2):563–565.
12. Obiechina NJ. Hypertensive disorders of pregnancy among primigravida and multigravida women in Nigeria. Niger J Clin Pract. 2019;22(4):527–533. doi:10.4103/njcp.njcp_246_18.
13. Maqsood R, Malik M, Hayat A, Shoukat I, Khalid M, Altaf W. Pre-eclampsia: a cross-sectional study conducted on multigravida females. Rawal Med J. 2022;47(2):396–399.
14. Cunningham FG, Leveno KJ, Bloom SL. Williams Obstetrics. 25th ed. New York: McGraw-Hill Education; 2018.
15. Wahyunindita RN, Sari RDP. Severe pre-eclampsia with partial HELLP syndrome in multigravida preterm pregnancy. Indones J Glob Health Res. 2022;4(1):1–8.
16. American College of Obstetricians and Gynecologists (ACOG). Gestational hypertension and preeclampsia. Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237–e260.
17. Jaydeb M, Roy D. Feto-maternal outcome study in hypertensive disorders of pregnancy: primigravida vs multigravida. Int J Reprod Contracept Obstet Gynecol. 2021;10(3):920–929. doi:10.18203/2320-1770.ijrcog20210647.
18. Fitrianingtyas R. The relationship of gravida with the incidence of preeclampsia in pregnant women at RSIA Muhammadiyah Probolinggo. Fetus J Midwifery. 2024;1(1):88–97.
19. Al-Mazgagi A, Al-Busaili T, Al-Ghomairi S, Al-Habeet A. A comparative study of feto-maternal outcome among preterm primigravida and multigravida attending Al-Sabeen Hospital, Sana’a City, Yemen. Al-Razi Univ J Med Sci. 2022;6(1):8–17.
20. Prasad S, Shivkumar PV, Haswani R. A prospective study of maternal and perinatal outcomes in eclampsia in a tertiary care centre. J Obst Gynecol Surg. 2022;3(2):23–26.
21. Rashid S, Izhar S, Kadri S, Ghafoor S, Abdullah A. Pre-eclampsia and pregnancy outcome: a population-based case-control study in Karachi, Pakistan. Med Forum. 2021;32(6):104–106.
22. Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. doi:10.1136/bmj.i1753.
23. Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol. 2008;198(4):428.e1–428.e6. doi:10.1016/j.ajog.2007.10.783.
24. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074. doi:10.1016/S0140-6736(06)68397-9.
25. Siddique AB, Perkins J, Mazumder T, Haider MR, Banik G, Tahsina T, et al. Antenatal care in rural Bangladesh: gaps in adequate coverage and content. PLoS One. 2018;13(11):e0205149. doi:10.1371/journal.pone.0205149.
26. World Health Organization. WHO recommendation on calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications. Geneva: World Health Organization; 2023. Available from: https://www.who.int/tools/elena/interventions/calcium-prepregnancy